Oct 25 (Reuters)-
Kainos Laboratories Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2022 Sep 30, 2021 Mar 31, 2023
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 2.51 2.33 5.10
(+7.8 pct) (+11.7 pct) (+10.5 pct)
Operating 511 mln 442 mln 900 mln
(+15.6 pct) (+37.9 pct) (+20.4 pct)
Recurring 527 mln 444 mln 900 mln
(+18.7 pct) (+36.2 pct) (+15.7 pct)
Net 358 mln 301 mln 600 mln
(+19.2 pct) (+49.9 pct) (+17.1 pct)
EPS 85.99 yen 73.58 yen 143.75 yen
Ann Div 25.00 yen 25.00 yen
-Q2 div NIL NIL
-Q4 div 25.00 yen 25.00 yen
NOTE - Kainos Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T